Immunovant, Inc. (a Delaware corporation) 12,500,000 Shares of Common Stock UNDERWRITING AGREEMENTLetter Agreement • October 4th, 2022 • Immunovant, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 4th, 2022 Company Industry Jurisdiction